The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.
Inspection Record
Alcon Canada Inc — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The annual product quality review procedure was inadequate.
The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.
The temperature and/or humidity control was inadequate.
Investigations into deviations, reports, and/or follow-up actions were inadequate.
The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. The retention time for records was inadequate. The handling of standard operating procedures for good manufacturing practices was inadequate.
The written procedures and records for retaining samples were inadequate.
The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080).
The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.
The assessment to release finished products was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2021-11-24. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
